Correlation Between Genmab AS and AP Mller

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and AP Mller at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and AP Mller into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and AP Mller , you can compare the effects of market volatilities on Genmab AS and AP Mller and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of AP Mller. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and AP Mller.

Diversification Opportunities for Genmab AS and AP Mller

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Genmab and MAERSK-A is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and AP Mller in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AP Mller and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with AP Mller. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AP Mller has no effect on the direction of Genmab AS i.e., Genmab AS and AP Mller go up and down completely randomly.

Pair Corralation between Genmab AS and AP Mller

Assuming the 90 days trading horizon Genmab AS is expected to under-perform the AP Mller. But the stock apears to be less risky and, when comparing its historical volatility, Genmab AS is 1.59 times less risky than AP Mller. The stock trades about -0.12 of its potential returns per unit of risk. The AP Mller is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  1,178,000  in AP Mller on September 3, 2024 and sell it today you would lose (21,000) from holding AP Mller or give up 1.78% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Genmab AS  vs.  AP Mller

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
AP Mller 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in AP Mller are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, AP Mller sustained solid returns over the last few months and may actually be approaching a breakup point.

Genmab AS and AP Mller Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and AP Mller

The main advantage of trading using opposite Genmab AS and AP Mller positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, AP Mller can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AP Mller will offset losses from the drop in AP Mller's long position.
The idea behind Genmab AS and AP Mller pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine